8-Cyclopropyl-4-(3-(6-(4-(3-hydroxypiperidine-1-carbonyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

Catalog No. :
ACBWCD404
CAS No. :
1472034-09-5
Molecular Formula :
C37H35N5O4
Molecular Weight :
613.72

IUPAC Name:8-cyclopropyl-4-(3-(6-(4-(3-hydroxypiperidine-1-carbonyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

8-Cyclopropyl-4-(3-(6-(4-(3-hydroxypiperidine-1-carbonyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Cyclopropyl-4-(3-(6-(4-(3-hydroxypiperidine-1-carbonyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
IUPAC Name8-cyclopropyl-4-(3-(6-(4-(3-hydroxypiperidine-1-carbonyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2-methylphenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
Molecular FormulaC37H35N5O4
Molecular Weight613.72
SMILESO=C(C=1C=CC(=CC1)C2=CC=3C(=NC=NC3C=4C=CC=C(C4C)N5C(=O)C6=CC=C(C=C6OCC5)C7CC7)N2)N8CCCC(O)C8
InChI KeyJPYZCFVWLXUCRN-UHFFFAOYSA-N
CAS No.1472034-09-5

Synthetic Route by SureRoute

1. ACBWCD404 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBWCD404 route product structure diagram
    ACBWCD4041472034-09-5
Inquiry

2. ACBWCD404 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBWCD404 route product structure diagram
    ACBWCD4041472034-09-5
Inquiry

Comments (0)